Cours Earth Science Tech, Inc. Other OTC
Actions
ETST
US2703111037
Produits pharmaceutiques
CA 2022 | 14,12 k 12,9 k | CA 2023 | 48,54 k 44,33 k | Capitalisation | 9,24 M 8,44 M |
---|---|---|---|---|---|
Résultat net 2022 | 3 M 2,74 M | Résultat net 2023 | - 0 | VE / CA 2022 | 103 x |
Dette nette 2022 | 656 k 599 k | Dette nette 2023 | 1,06 M 964 k | VE / CA 2023 | 212 x |
PER 2022 |
0,25
x | PER 2023 |
-13,8
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 39,89% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 01/10/22 |
Mario Tabraue
COO | Chief Operating Officer | 45 | 01/11/21 |
Sergio Castillo
SAM | Sales & Marketing | 40 | 25/01/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mario Tabraue
COO | Chief Operating Officer | 45 | 01/11/21 |
Giorgio Saumat
CEO | Chief Executive Officer | 44 | 01/10/22 |
Yovan Sanchez
BRD | Director/Board Member | 43 | 07/11 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |